Member Info for volcano

AA it has been on my watch list for a wile now , at this levels not a bad entry .
have you bought in yet?
43.70 GBX -0.12 (0.27%)
20 Feb, 09:58 GMT · Disclaimer

2nd Support Level 61.667

Also in demand early on were shares in Lloyds Banking Group (LON:LLOY), a particular favourite of private investors.

The stock was up 2.3% with investors appearing impervious to the latest round of payment protection (PPI) claims.

“Today’s final numbers for 2019 have confirmed the bank set aside a total of £2.5bn PPI provision for this year alone, a big chunk of change for a bank that has seen its profits squeezed anyway as a result of narrowing interest margins,” said Michael Hewson of CMC Markets.

“The upside to all of this is that at least the PPI saga looks to be finally behind them, with no further provisions made in this quarter, so there’s a big silver lining there.”

Credit Suisse initiated coverage of Royal Bank of Scotland with an 'outperform' rating and a price target of 260.0p, and Lloyds Banking Group and Barclays with 'neutral' ratings and price targets of 60.0p and 185.0p, respectively.

and the share price is getting better as well.
57.68 GBX +1.90 (3.41%)
20 Feb, 08:15 GMT · Disclaimer

looking good so far
56.56 GBX +0.78 (1.40%)
20 Feb, 08:05 GMT · Disclaimer

today will be back to normal ,yesterday was a gift ,nice though.

yes i agree mate, EMG boghth back tiny amount of shares yesterday ,i buy and sell more than that . come on boys and girls.

Man Group plc (the "Company") announces that on 19 February 2020 it purchased 26,306 of its ordinary shares with a weighted average price of 157.7225 pence per ordinary share pursuant to its US$100 million share repurchase programme, details of which were announced on 14 October 2019. The highest price paid per share was 159.0 pence and the lowest price paid per share was 156.2 pence. Details of the relevant repurchase transactions are set out below:

yes i agree mate and more to come ,
Broker: Credit Suisse Securities (Europe) Limited



Since the commencement of the share repurchase programme, the Company has repurchased 18,133,453 ordinary shares in aggregate at a weighted average price of 149.99173 pence per share.



The Company intends to hold the purchased shares in treasury. Following the purchase and settlement of these shares, the Company will hold 28,888,162 of its ordinary shares in treasury and will have 1,512,906,608 ordinary shares in issue (excluding treasury shares). (Note: This figure takes into account the transfer from treasury of 4,000 ordinary shares on 18 February 2020 in order to satisfy the exercise of options under the Company's Sharesave Scheme).



All transactions under this programme will be published on the Company's website (www.man.com) on a weekly basis.

i am opposite to you holding big amount and selling on the spike ,so my buy this morning is gone already.

you have done well mate, LGEN share price is up £1 in the last five months, not bad return . i remember trading LGEN at 25p yes that is correct no misprint here.

I wish i have got this news before 08.00 am today like the most investment companies.

Man Group Ltd 11.5% Potential Upside Indicated by Exane BNP Paribas

Posted by: Amilia Stone 19th February 2020

Man Group Ltd with EPIC/TICKER (LON:EMG) has had its stock rating noted as ‘Upgrades’ with the recommendation being set at ‘OUTPERFORM’ this morning by analysts at Exane BNP Paribas. Man Group Ltd are listed in the Financials sector within UK Main Market. Exane BNP Paribas have set a target price of 170 GBX on its stock.

Man Group, up 7.0%. Exane BNP raised the asset manager to Outperform from Neutral.

demand will rise as people live longer .
IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.

Short walk and i am back and little bit relaxed, looks like EMG is settled around 160p .Next time more patience needed .

Hi Gerry , i shouldn't have worried about EMG ,
doing great today.
160.00 GBX +11.15 (7.49%)
19 Feb, 09:22 GMT · Disclaimer

Someone told me never trade before 09.00 let the market finds his legs ,well looks like i don't take any notice of anyone and that was twenty five years ago. And why the MM drop the price yesterday with no news , was it family and friends day lol. I am going for a walk , markets !!!

Morbox, Barchart has strong sell on EMG , you never know who is right and who is wrong one thing i know i have missed out on a grand so far today ,oh well next time maybe,lol.

Full year results for the year ended
31 December 2019 28 Feb 2020

Well done mate , i have just seen it, i thought i missed the boat there but looks like i was wrong.